Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the 11 most popular AI penny stocks to buy now. On February 25, ...

Recursion Pharmaceuticals, Inc ( (RXRX)) has held its Q4 earnings call. Read on for the main highlights of the call.

Today is Microsoft's March 2026 Patch Tuesday with security updates for 79 flaws, including 2 publicly disclosed zero-day ...

Artificial intelligence is rapidly inventing new drugs for diseases from Parkinson's disease and antibiotic-resistant superbugs to rare lung conditions.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the Low Risk Penny Stocks to Buy Now. On February 27, Bank of America ...

array(1) { [0]=> object(AdvItems)#303 (17) { ["image"]=> NULL ["delete_image"]=> NULL ["publish_start_int"]=> string(10) "1772305246" ["publish_end_int"]=> string(10 ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Boston College will begin recruiting the first class for its highly anticipated Human-Centered Engineering program, a major that will integrate BC’s core liberal arts focus and a rigorous engineering ...

The 2026 Pathways Research Explorers online application is now open. Please use the link to Apply Now! Applications close 11:59 pm PST March 6, 2026.

For Immediate Broadcast or Online Closed Captioning or Audio Description Concerns contact Joe Kern at 215-977-5202. For Written Broadcast or Online Closed Captioning or Audio Description Complaints, ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...